Immune on SPi NewsFollow our SPi News RSS Feed for immune

Featured immune News

[10 Sep 2019] Immune Therapeutics Revises and Resends Proxy Statement

[15 May 2019] Immune Therapeutics, Inc. Provides Shareholder Update on 14A

[02 Apr 2019] FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin

[19 Mar 2019] VBL Presents New Data on Potential of VB-111 to Stimulate the Immune System and Drive Immune Cells to Infiltrate Tumor Microenvironment

[19 Feb 2019] Immune Pharmaceuticals Files for Chapter 11 Protection

[13 Dec 2018] Immune-checkpoint Drugs in Oncology Analytical Tool, 2018 - 234 Companies Plus Partners, Developing 560 Immune-Checkpoint Drugs

[12 Dec 2018] AC Immune and Lilly Announce License and Collaboration Agreement

[11 Dec 2018] Global Immune Checkpoint Inhibitors Market Outlook to 2023 - High Target Affinity & Specificity of Immune Checkpoint Inhibitors Drugs is Driving Growth

[19 Nov 2018] Immune Pharmaceuticals Reschedules Corporate Update Call

[16 Nov 2018] Immune Pharmaceuticals Schedules Corporate Update Call

[12 Nov 2018] AC Immune to Present at the Jefferies 2018 London Healthcare Conference

[01 Nov 2018] AC Immune to Present at 2018 Society for Neurosciences Meeting

[17 Oct 2018] Immune Pharmaceuticals Announces Positive Preclinical Results in Asthma

[10 Oct 2018] Immune Pharmaceuticals Announces $5 Million Financing

[13 Sep 2018] Immune Pharmaceuticals Provides a Corporate Update

[02 Aug 2018] Immune Pharmaceuticals Postpones Special Meeting of Stockholders

[31 Jul 2018] AC Immune Announces Successful Closing of Second Subscription Rights Offering

[25 Jul 2018] Immune Therapeutics Inc Announces Publication of Peer Reviewed Scientific Paper Describing Low-Dose Naltrexone (LDN): A Promising Treatment in Immune-Related Diseases and Cancer Therapies

[17 Jul 2018] AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares

[10 Jul 2018] Cyrus Biotechnology Launches Immune Epitope Prediction Software

[06 Jul 2018] AC Immune Announces Results of Annual General Meeting

[23 May 2018] Immune Pharmaceuticals Provides a Pipeline Update

[27 Apr 2018] AC Immune Announces Results of Extraordinary Shareholders Meeting

[09 Feb 2018] Immune Design to Present at Upcoming Investor Conferences

[26 Dec 2017] New study redefines Down syndrome as immune system disorder

[23 Aug 2017] Immune Therapeutics, Inc. Appoints John H. Abeles, M.D. as Chairman and CEO of Company’s Subsidiary, Cytocom, Inc. and as Senior Adviser to Immune Therapeutics, Inc.

[28 Jun 2017] AC IMMUNE ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING

[11 May 2017] AC IMMUNE SA REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS

[25 Apr 2017] Immune Therapeutics, Inc. Files Lodonal New Drug Application in Kenya

[10 Feb 2017] Immune Design to Present at Upcoming Investor Conferences

[02 Feb 2017] Immune Therapeutics Clears Critical Certification Milestone

[30 Jan 2017] UPDATE -- Immune Therapeutics Issues Special Letter to Shareholders

[30 Jan 2017] Immune Therapeutics Issues Special Letter to Shareholders

[15 Nov 2016] AC Immune SA announces results of annual general meeting

[11 Nov 2016] AC Immune Reports Third Quarter 2016 Results

[23 Sep 2016] Switzerland's AC Immune Opens For Trading On NASDAQ

[02 Aug 2016] Immune Design to Report Second Quarter 2016 Financial Results

[16 Jun 2016] Immune Design Appoints Susan L. Kelley, M.D. to Board of Directors

[07 Jun 2016] Cooper Releases “Discovery2” Human Immune System Simulator

[01 Jun 2016] Immune Design Announces Upcoming Events

[20 May 2016] Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis Report 2016 - The Global Immune Checkpoint Therapeutics Market Is Estimated to Reach $40.8 Billion by 2022

[17 May 2016] Immune Design to Present at UBS Global Healthcare Conference 2016

[04 Mar 2016] Immune Design’s GLAAS™ Platform Shown to Modulate the Allergic Immune Response

[30 Sep 2015] Is 50 Really the New 30? Your Immune System May Not Think So

[18 Aug 2015] Immune Checkpoint Inhibitors Market, 2014-2024

[10 Aug 2015] Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma

[11 May 2015] Immune Design to Present at Upcoming Investment Conferences

[10 Sep 2014] Emergen-C Immune+ Launches Four New Flavors with Wellmune WGP

[14 Jul 2014] Immune Appoints Cameron Durrant, MD, MBA to Board of Directors

[25 Jun 2014] IMMUNE Partners With Patient Community Group LYFEBULB


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

Publish Your Stories with SPI

Please click here to find out how to submit press releases and articles for publication.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us